PDCD1 and non-small cell lung carcinoma: The primary aim of our retrospective study was to evaluate the association between GLCM-entropy in 18F-FDG PET/CT and response to anti-PD-1/PD-L1 monotherapy at first evaluation in extensive-stage NSCLC, comparing patients with progressive disease (PD) and non-progressive disease (non-PD).